JESSICA MILLAY: Open Payments
NPI 1457982969 · BEAVER DAM, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 37 payments from 10 companies in 2025. Trend: 2023 $1,544 · 2024 $1,054 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $243 |
| Corcept Therapeutics | 9 | $220 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| PFIZER INC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $25 |
Products named: Korlym, QULIPTA, REXULTI, CAPLYTA, UBRELVY, VRAYLAR, NURTEC ODT, Kerendia.
Industry payments across KY — which companies pay providers there.
